<abstract xmlns="http://www.w3.org/1999/xhtml">Cough is a common symptom encountered in medical practice and can occur throughout the life of a person. From a physiological point of view, it represents a mechanism responsible for the elimination of secretions from the airways. At the same time, cough may be the first symptom of an illness. There are many causes that may lead to the emergence of a chronic cough syndrome, the most frequent being pulmonary diseases. Besides the bronchopulmonary pathology, there are a number of extrapulmonary disorders that may manifest with coughing. The first step in evaluating the patient with chronic cough is performing a correct and complete anamnesis, followed by the physical examination of the patient. The treatment of the chronic cough syndrome must address mainly the underlying disease but, in case of failure of the established treatment, the antitussive therapy is used.</abstract>

The chronic cough syndrome

<abstract xmlns="http://www.w3.org/1999/xhtml">Nasal reconstruction is challenging, considering surgical techniques complexity and difficulties in remodelling a tridimensional structure. Reconstructive requirements are: correct deformity evaluation, selecting the most suitable treatment option, respecting the principle of aesthetic subunit, appropriate reconstruction of each affected nasal layer, long-term stabile functional and aesthetic results. Reconstructive procedures range from simple to very complex. Conventional techniques can fail in restoring a satisfactory appearance in severely disfigured patients, for whom a new possibility arises: Vascularized Composite Allografts (VCA) transplantation.In this paper, we focus on nasal skeletal framework restoration. Structural defects may require a large amount of reconstructive material obtained usually from cartilage or bone autografts. Autologous cartilage is the gold standard in nasal architectural recovery, but in some cases, autologous graft sources are not available, imposing the necessity to use alternative solutions represented by the allografts or alloplastic materials. We analysed the specific features of skeletal allografts used in nasal reconstruction.With current clinical experience, the use of cartilage and bone allografts (especially irradiated cartilage homografts) shows a promising reconstructive option for nasal structural defects. For extensive facial defects, including midface deformities, impossible to restore with traditional surgical techniques, a new reconstructive era was open through the development of the VCA field.</abstract>

Department of Plastic Surgery, Aesthetic and Reconstructive Microsurgery, Emergency Clinical Hospital, Bucharest, Romania

ENT&HNS Department, “Sfanta Maria“ Hospital, Bucharest, Romania

The role of cartilage and bone allografts in nasal reconstruction

<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>OBJECTIVE.</bold> The purpose of this study was to compare the options for treatment of Miller’s Class I and Class II gingival recessions using coronally advanced flap (CAF) and platelet-rich fibrin membrane (PRFm) with CAF and connective tissue graft (CTG).<bold>MATERIAL AND METHODS.</bold> A surgical treatment was carried out on 30 subjects (23 women and 7 men), with a total of 118 symmetrical recessions of Class I and Class II by Miller on different places of the jaws, using two different methods. On one side of the jaw was held a plastic covering of the recessions with CAF in combination with PRFm (test group), and on the other side – CAF in combination with connective tissue graft (control group). The clinical evaluation includes: gingival recession depth (GRD), probing pocket depth (PPD), clinical attachment level (CAL), keratinized gingival width (KGW), gingival thickness (GTH), mean percent of root coverage (RC %). The results were observed six months postoperatively.<bold>RESULTS.</bold> The average values for the GRD measured six months postoperatively for the control group were 0.37±0.36 mm and 0.70±0.41 mm for the test group. The results for CAL for the control group were 2.01±0.44 mm and 2.28±0.50 mm for the test group, while the mean percentage of root coverage (RC %) was 90.29±9.05% for the control group and 80.48±10.19% for the test group. The values for GTH were 1.04±0.16mm for the control group and 0.92±0.09 mm for the test group.<bold>CONCLUSION.</bold> Both compared methods show good results in terms of all evaluated parameters. The group treated with CAF + CTG showed better results with a statistically significant difference for the RC% and the average values for GRD, GTH and CAL. The results of our study demonstrate a good potential for PRFm used in the treatment of Miller’s Class I and Class II gingival recessions.</abstract>

Department of Oral Surgery, Faculty of Dental Medicine, Plovdiv Medical University, Plovdiv, Bulgaria

Department of Otorhinolaryngology, Faculty of Medicine, Plovdiv Medical University, Plovdiv, Bulgaria

The treatment of gingival recessions - Our experience

<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>BACKGROUND.</bold> Nasal obstruction may trigger obstructive sleep apnea syndrome (OSAS) and it is considered to be a cofactor in its pathophysiology. However, the relation between cause and effect still remains a matter of debate.<bold>MATERIAL AND METHODS.</bold> 18 patients diagnosed with chronic hypertrophic rhinitis and obstructive sleep apnea syndrome were included in the present study. All patients underwent nasal surgery as the single treatment for their sleep breathing disorders. Rhinomanometric (total nasal airflow, logReff, logVR) and polygraphic parameters (apnea-hypopnea index - AHI, snore flags index – SFI) were evaluated pre- and 2 months postoperatively.<bold>RESULTS.</bold> There was a statistically significant difference between the values of the preoperative and postoperative total nasal airflow (p-value&lt;0.0001). In case of AHI, there was a decrease in its value from 31.56 preoperatively to 30.03 postoperatively, but the difference was not statistically significant (p=0.937). The SFI, on the other hand, presented a significant decrease (p=0.05), from a mean value of 93.15 preoperatively to 56.02 after the surgery. The correlation of the total nasal airflow with AHI and SFI, revealed that nasal surgery had an important impact upon snoring characteristics (r=0.24) and less upon OSAS severity (r=0.21).<bold>CONCLUSION.</bold> The nasal cavity obstruction contributes less to OSAS, but still represents a disorder that needs to be corrected in case of such patients. Turbinates reduction surgery may be applied in the treatment of OSAS and combined with palate and/or tongue surgery.</abstract>

ENT&HNS Department, “Sfanta Maria” Hospital, Bucharest, Romania

“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

ENT Sarafoleanu Medical Clinic, Bucharest, Romania

Do the turbinates play an important role in obstructive sleep apnea syndrome? – Our experience

<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>BACKGROUND.</bold> Radiotherapy, associated with chemotherapy, is the main method of treatment in both early and advanced stages of nasopharyngeal carcinoma. Intensity modulated radiation therapy (IMRT) provides high doses of radiation to the primary tumor, sparing the organs at risk. Volumetric modulated arc therapy (VMAT) is one of the most promising radiation methods which produces superior target coverage, improving the protection of organs at risk and reduces treatment time.<bold>MATERIAL AND METHODS.</bold> We performed a retrospective study on 30 patients diagnosed with nasopharyngeal cancer and admitted in “Sfanta Maria” Clinical Hospital between October 2012 and December 2014. All patients have undergone VMAT-IMRT associated with induction or concurrent chemotherapy. At the end of the treatment, patients were followed up at one, three and six months, and then every six months for 2 years.<bold>RESULTS.</bold> At the end of the radio-chemotherapy treatment, 27 patients (90%) had a complete tumor and lymphatic response and 3 of them (10%) presented a partial response. At the end of the follow-up period, we observed 5 patients with recurrences, including 2 deceased.<bold>CONCLUSION.</bold> VMAT-IMRT in association with chemotherapy treatment is well tolerated by patients. The good results reflected in high rates of cured patients, the low incidence of side effects, recommend this treatment plan as an optimal indication for nasopharyngeal tumors.</abstract>

Advantages of VMAT-IMRT technique in nasopharyngeal cancer

<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>BACKGROUND.</bold> The infraorbital recess of the maxillary sinus can reach in front of the nasolacrimal duct to become prelacrimal recess. During a routine Cone Beam CT (CBCT) study of a male patient of 72 years old, there were bilaterally found infraorbital maxillary air cells (IMACs) resulted after the almost complete closure of infraorbital recesses of the maxillary sinuses. Only that on the left side was reaching in front of the nasolacrimal canal. The closure of each infraorbital recess leaded to a narrow draining passage opened in the terminal end of the maxillary infundibulum, thus proximal to the maxillary sinus ostium. On the left side, a small cell of the lacrimal bone was interposed between the IMAC drainage pathway and the nasolacrimal canal. On the right side, the nasolacrimal canal was communicating with the ethmoidal infundibulum. Such an anatomic variation in the infraorbital angle of the maxillary sinus can impede the endoscopic procedures which use the anterior lacrimal pathway.</abstract>

Division of Anatomy, Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

Division of Oral Implantology, Faculty of Dental Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

Bilateral infraorbital maxillary air cells: recess-derived non-Haller cells

“Carol Davila” University of Medicine and Pharmacy, Bucharest

Frontal sinus osteoma

AHEAD OF PRINT

Volume 14 (2024): Issue 54 (April 2024)

Volume 14 (2024): Issue 53 (March 2024)

Volume 13 (2023): Issue 52 (December 2023)

Volume 13 (2023): Issue 51 (July 2023)

Volume 13 (2023): Issue 50 (April 2023)

Volume 13 (2023): Issue 49 (March 2023)

Volume 12 (2022): Issue 48 (December 2022)

Volume 12 (2022): Issue 47 (July 2022)

Volume 12 (2022): Issue 46 (April 2022)

Volume 12 (2022): Issue 45 (March 2022)

Volume 11 (2021): Issue 44 (December 2021)

Volume 11 (2021): Issue 43 (September 2021)

Volume 11 (2021): Issue 42 (June 2021)

Volume 11 (2021): Issue 41 (March 2021)

Volume 10 (2020): Issue 40 (December 2020)

Volume 10 (2020): Issue 39 (September 2020)

Volume 10 (2020): Issue 38 (June 2020)

Volume 10 (2020): Issue 37 (March 2020)

Volume 9 (2019): Issue 36 (December 2019)

Volume 9 (2019): Issue 35 (September 2019)

Volume 9 (2019): Issue 34 (June 2019)

Volume 9 (2019): Issue 33 (March 2019)

Volume 8 (2018): Issue 32 (October 2018)

Volume 8 (2018): Issue 31 (September 2018)

Volume 8 (2018): Issue 30 (June 2018)

Volume 8 (2018): Issue 29 (March 2018)

Volume 7 (2017): Issue 28 (December 2017)

Volume 7 (2017): Issue 27 (September 2017)

Volume 7 (2017): Issue 26 (June 2017)

Volume 7 (2017): Issue 25 (March 2017)

Volume 6 (2016): Issue 24 (December 2016)

Volume 6 (2016): Issue 23 (September 2016)

Volume 6 (2016): Issue 22 (June 2016)

Volume 6 (2016): Issue 21 (March 2016)

Volume 5 (2015): Issue 20 (December 2015)

Volume 5 (2015): Issue 19 (September 2015)

Volume 5 (2015): Issue 18 (June 2015)

Volume 5 (2015): Issue 17 (March 2015)

Romanian Journal of Rhinology

Rhinology, as an important part of Otorhinolaryngology, addresses a very frequent and diverse pathology, with important interdisciplinary implications. In the last decades, this medical field was the beneficiary of new technical means for accurate and effective investigation, treatment and research. The needs of modern medicine - over-specialization, interdisciplinary approach and evidence-based medicine, lead to the situation that the international rhinologic societies are the most dynamic and appreciated.  The Romanian Journal of Rhinology is the official scientific publication of the Romanian Rhinologic Society, and it is trying to fill the existing gap in the Romanian ENT literature, promoting modern publishing and criteria according to the international standards. Romanian Journal of Rhinology appears quarterly with the purpose to publish original articles, original clinical reports, clinically relevant experimental studies and short communications presenting new results of general interest. Its aim is to concentrate and provide information concerning care, cure and prevention of different rhinologic disorders and borderline pathology. With a peer review by an important national and international editorial board, the journal provides clinical and clinically related information written by authors from all over the world.  Journal’s business model  Romanian Journal of Rhinology is an Open Access journal. The submission and publication of the articles are free of charge, in both print and electronic publication. The publisher covers all costs – editing, printing, copyediting, typesetting, long-term archiving, journal management.  Romanian Journal of Rhinology is the journal of the Romanian Rhinologic Society; thus, one of the financial sources for publication is represented by the Society from the manuscript fees.  Advertisements represent another important founding source. The decision regarding the type of advertisements, acceptance/rejections, the price offering is made by the Publishing/technical Editor, the Editorial Board having no decision power on this aspect. Advertorials and publicity about pharmacological devices, drugs, supplements related to rhinologic and otolaryngologic pathologies can be taken into consideration. In case of Advertorials, with an important scientific content, the medical data presented will have the approval of the Journal’s Editors.  There is also available the annual subscription for individuals and companies. The contact person is also the Publishing/technical Editor.  Publication schedule  The Romanian Journal of Rhinology is published quarterly:   January-March (publication month: February)  April-June (publication month: April)  July-September (publication month: July)  October-December (publication month: October)  Editorial process  The Romanian Journal of Rhinology uses a standard scheme for the evaluation process of the submitted articles. All manuscripts are strictly reviewed for originality, correctness, methodology, quality of the medical information, suitability for the journal’s medical field, ethical nature.  The Editors reserve the right to refuse any manuscript which does not correspond to the submission guidelines.  Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the otorhinolaryngology area assess the submitted manuscripts for originality, validity, and significance to help editors determine whether the manuscript should be published in their journal.  After submission:   All manuscript are treated as confidential documents, all being assigned with a registration number (for example, RJR010121 (day of submission)(month of submission) (the last two numbers of the year of submission)). All communications between the editors, the author(s), the reviewers are made by using this identification number.  Technical review performed by the editor-in-chief, associated editors, members of the editorial board analyses – the importance of the subject, presentation clarity, relevance, plagiarism index. Submissions that fail to fulfil all requirements are rejected. This process last for a few days after submission.  Review process. The Romanian Journal of Rhinology has a double-blind reviewing process, in which the reviewers do not know the names of the authors, and the authors do not know who reviewed their manuscript. Therefore, the authors are required to submit a blind manuscript without the authors’ names and affiliations on the title page or in the text and a separate title page with the names of the authors, affiliations, and information about the corresponding author. After the initial assessment for, submissions are sent to at least two experts in the field who are asked to evaluate whether the manuscript is scientifically coherent, easy to read, useful in the field, and whether the manuscript should be accepted, rejected or revised. The review process will take approximately 2 weeks. After the review process is completed, the corresponding author will receive an e- mail about the evaluation results of the submitted manuscript: accepted, revision or rejection. If the e-mail contains suggestions and comments for revising the manuscript, the authors should make the changes and return to the editor within 2 weeks; if not, the manuscript is considered rejected. If the manuscript is accepted for publication by the reviewers, it is forwarded to the Editor-in-Chief. The final decisions are made by the Editor-in-Chief based on the recommendations of reviewers reports and the journal’s editors. Where necessary, they will consult with members of the Editorial Board. The Editor-in-Chief may advice the corresponding author to make necessary revisions in order to publish the article. The final form of the article will be sent to the main author for the last approval from his/her part (if there are minor changes these should be send in no more than 1 week).  The publication process after the article’s submission may take 45 days, average. All accepted articles are assigned with a DOI number.  The Romanian Journal of Rhinology follows the International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and required ICMJSE to be listed as a journal that follows these recommendations.  Archiving  Sciendo archives the contents of this journal in Portico - digital long-term preservation service of scholarly books, journals and collections.  Plagiarism Policy  The editorial board is participating in a growing community of Similarity Check System's users in order to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 